Found 534 hits.
| 272 | Garbani, M., Xia, W., Rhyner, C., Prati, M., Scheynius, A., Malissen, B., Engqvist, H., Maurer, M. Crameri, R., and Terhorst, D.: Allergen-loaded strontium-doped hydroxyapatite spheres improve allergen-specific immunotherapy in mice. Allergy 2017: 72; 570-578. IF: 6.05 |
| 223 | Kay, A. B.+, Clark, P., Maurer, M. and Ying, S.: Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (“idiopathic”) urticaria. Brit. J. Dermatol. 2015: 172; 1294-1302. IF: 4.31 |
| 392. | Sommer, R.+, Silva, N., Langenbruch, A., Maurer, M., Staubach, P., and Augustin, M.: Characteristics and determinants of patient burden and needs in the treatment of chronic spontaneous urticaria. Eur. J. Dermatol. 2020: 30; 259-266. IF: 3.33 |
o.392
| 102. | Kolkhir, P., Pogorelow, D., Olisova, O., and Maurer, M.+: Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus – a systemic review. Clin. Exp. Allergy 2016: 46; 275-287. IF: 5.26 |
| 313 | Maurer, M. Mathias, S. D., Crosby, R. D., Rajput, Y.+, and Zazzali, J. L.: Validity and responsiveness of the urticaria activity and impact measure: a new patient-reported tool. Ann. Allergy Asthma Immunol. 2018: 120; 641-647. IF: 3.56 |
| 387. | Weller, K.+, Donoso, T., Magerl, M., Aygören-Pürsün, E., Staubach, P., Martinez-Saguer, I., Hawro, T., Altrichter, S., Krause, K., Siebenhaar, F., Metz, M., Zuberbier, T., Freier, D., and Maurer, M.: Development of the angioedema control test (AECT) – a patient reported outcome measure that assesses disease control in patients with recurrent angioedema. Allergy 2020: 75; 1165-1177. IF: 13.15 |
o.387
| 411. | Agache, I.+, Song, Y., Posso, M., Alonso-Coello, P., Rocha, C., Solà, I., Beltran, J., Akdis, C., Akdis, M., Brockow, K., Chivato, T., del Giacco, S., Eiwegger, T., Eyerich, K., Giménez-Arnau, A., Gutermuth, J., Guttman-Yassky, E., Maurer, M., Ogg, G., Ong, P. Y., O’Mahony, L., Schwarze, J., Werfel, T., Canelo-Aybar, C.*, Palomares, O.*, and Jutel, M.*: Efficacy and safety of Dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI biologicals guidelines. Allergy 2021: 76; 45-58. IF: 14.71 |
o.411
| 65. | Church, M. K. and Maurer, M.: H1-antihistamines and urticaria: how can we predict the best drug for our patient? Clin. Exp. Allergy 2012: 42; 1423-1429. IF: 4.78 |
| 167. | Maltseva, N., Borzova, E., Fomina, D., Bizjak, M., Terhorst-Molawi, D., Košnik, M., Kulthanan, K., Meshkova, R., Thomsen, S. F., and Maurer, M.+: Cold urticaria – what we know and what we do not know. Allergy 2021: in press. IF: 14.71 |
r.167
| 131. | Church, M. K., Kolkhir, P., Metz, M., and Maurer, M.+: The role and relevance of mast cells in urticaria. Immunol. Rev. 2018: 282; 232-247. IF: 11.29 |